Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single-blind placebo-controlled pilot study of BAY 1067197 in chronic heart failure with background beta-blocker therapy
2013-001287-34Phase 2Completed
- Sponsor
- Bayer
- Start
- Aug 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial in heart failure (HF) comparing BAY 1067197 + beta-blocker with Placebo + beta-blocker (2 arms). Primary endpoint: Occurrence of AV block > first degree within 48 hours. Started Aug 2013; status: completed.
02
Drugs
neladenoson bialanate
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on 2013-001287-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-001287-34.